Get the Weekly Intelligence Brief — top committee picks every Sunday.

ACAD vs REPL

ACADIA Pharmaceuticals Inc. vs Replimune Group, Inc. — AI-powered side-by-side comparison
ACAD
ACADIA Pharmaceuticals Inc.
69
Buy
VS
REPL
Replimune Group, Inc.
54
Watch
MetricACADREPL
AI Score 69 54
Price $29.41 $13.67
P/E Ratio 13.07× -4.04×
ROE 31.9% -188.9%
Revenue Growth YoY
Gross Margin 91.1% 0.0%
Debt / Equity 0.06× 0.67×
Dividend Yield 0.0% 0.0%
RSI (14) 78.4 70.3
Beta 0.845 0.9
Expected Upside

AI Committee View

Current Innellis committee reasoning for ACAD versus REPL.
ACAD leads by 15 points.

ACAD scores 69/100 (Buy) versus REPL at 54/100 (Watch).

ACAD Committee View
83% agreement
6 analysts

The primary driver is revenue growing 47.0% yoy -- genuine top-line momentum. The main limiting factor is bollinger bandwidth of 24.3% signals elevated volatility. The committee is constructive but not yet at full conviction.

Bull Case
  • P/E of 13.2 is inexpensive for the broad market — Value
  • ROE of 32.4% shows genuine earnings power backing the valuation — Value
  • Revenue growing 47.0% YoY -- genuine top-line momentum — Growth
Bear Case
  • RSI at 78 is in overbought territory — Technical
  • Weekly RSI at 80 -- overbought on the larger timeframe too — Technical
  • Bollinger bandwidth of 24.3% signals elevated volatility — Risk
REPL Committee View
40% agreement
5 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 96.8% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
  • ROE of only -128.6% -- cheap may mean cheap for a reason — Value
  • RSI at 70 is in overbought territory — Technical
  • Daily trend (uptrend) conflicts with the weekly trend (downtrend) -- fighting the larger trend — Technical
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ACAD Full Analysis REPL Full Analysis